DOSE Therapeutics, Inc.
Biotechnology company · Dallas, Texas, United States
DOSE Therapeutics, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2022.
DOSE Therapeutics at a glance
What does DOSE Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $10 million sold (2022).
Frequently asked questions about DOSE Therapeutics
Where is DOSE Therapeutics headquartered?
DOSE Therapeutics, Inc. is headquartered in Dallas, Texas, United States.
What does DOSE Therapeutics do?
DOSE Therapeutics, Inc. is a biotechnology company.
When was DOSE Therapeutics founded?
The earliest incorporation on record for DOSE Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- OncoNano Medicine, Inc.Dallas, Texas, United States
- Taysha Gene Therapies, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Stingray Therapeutics, Inc.Dallas, Texas, United States
- Qualia Oto, Inc.Dallas, Texas, United States
- EtiraRX, Inc.Dallas, Texas, United States
- CG Oncology, Inc.Dallas, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences